 <h1>Corvert Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>ibutilide</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about ibutilide. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Corvert.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to ibutilide: parenteral solution for injection</i></p><h3>Warning</h3><p><ul>
<li>
May cause potentially fatal arrhythmias.&lt;sup&gt;1&lt;/sup&gt; &lt;sup&gt;7&lt;/sup&gt;  Should be administered only by skilled personnel in a setting in which proper equipment (e.g., cardiac monitors, intracardiac pacing, cardioverter/defibrillator) and therapy for sustained VT are available during and after drug administration.&lt;sup&gt;1&lt;/sup&gt;  (See Arrhythmogenic Effects under Cautions.)</li></ul></p><ul>
<li>
May cause potentially fatal arrhythmias.&lt;sup&gt;1&lt;/sup&gt; &lt;sup&gt;7&lt;/sup&gt;  Should be administered only by skilled personnel in a setting in which proper equipment (e.g., cardiac monitors, intracardiac pacing, cardioverter/defibrillator) and therapy for sustained VT are available during and after drug administration.&lt;sup&gt;1&lt;/sup&gt;  (See Arrhythmogenic Effects under Cautions.)</li></ul><p>
<li>
Adequate anticoagulation recommended for patients with atrial fibrillation of more than 2–3 days’ duration.&lt;sup&gt;1&lt;/sup&gt;</li></p><p>
<li>
Select patients carefully such that the expected benefits of conversion to sinus rhythm outweigh the immediate risks of ibutilide therapy.&lt;sup&gt;1&lt;/sup&gt;  Use ibutilide when it is likely to offer an advantage compared with alternative management methods for atrial flutter or fibrillation.&lt;sup&gt;1&lt;/sup&gt;  (See Supraventricular Tachyarrhythmias under Uses.)</li></p><p></p><p>Side effects include:</p><p>Generally well tolerated.  Adverse events affecting the cardiovascular system (e.g., arrhythmogenic affects, affects on cardiac conduction, palpitation, hypotension, hypertension), nausea, and headache reported in ≤5.1% of patients. </p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to ibutilide: intravenous solution</i></p><h3>General</h3><p>The most common adverse reactions were ventricular extrasystoles, non-sustained monomorphic ventricular tachycardia, headache, and non-sustained polymorphic ventricular tachycardia.<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Common</b> (1% to 10%): Sustained polymorphic ventricular tachycardia, non-sustained polymorphic ventricular tachycardia, non-sustained monomorphic ventricular tachycardia, atrioventricular block, bundle branch block, ventricular extrasystoles, hypotension/postural hypotension, bradycardia/sinus bradycardia, tachycardia/sinus tachycardia/supraventricular tachycardia, hypertension, QT segment prolonged, palpitation, tachycardia</p><p><b>Uncommon</b> (0.1% to 1%): Sustained monomorphic ventricular tachycardia, supraventricular extrasystoles, nodal arrhythmia, congestive heart failure, idioventricular rhythm<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Common</b> (1% to 10%): Headache</p><p><b>Uncommon</b> (0.1% to 1%): Syncope<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Common</b> (1% to 10%): Nausea<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Renal failure<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Corvert (ibutilide)." Pharmacia and Upjohn, Kalamazoo, MI. </p><h2>More about Corvert (ibutilide)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Generic Availability</li>
<li>Drug class: group III antiarrhythmics</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Atrial Fibrillation</li>
<li>Atrial Flutter</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>